Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Hagens Berman urges Bright Health Group, Inc. (NYSE: BHG) investors with significant losses to submit your losses now.


GlobeNewswire Inc | Jan 24, 2022 09:33AM EST

January 24, 2022

SAN FRANCISCO, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Bright Health Group, Inc. (NYSE: BHG) investors with significant losses to submit your losses now.

Class Period: June 21, 2021 Nov. 10, 2021Lead Plaintiff Deadline: Mar. 7, 2022Visit:www.hbsslaw.com/investor-fraud/BHGContact An Attorney Now:BHG@hbsslaw.com 844-916-0895

Bright Health Group, Inc. (BHG) Securities Class Action:

The complaint alleges that Bright Health, senior executives and other responsible parties made false and misleading statements during and after the companys June 2021 initial public offering about the adaptability of the companys so-called alignment business model to continue to deliver improved medical cost ratios (MCR), a key metric dependent on capturing certain premium revenues.

Specifically, Defendants misrepresented and failed to disclose that Bright Health (1) overstated the companys post-IPO financial prospects in its offering documents, (2) was ill-equipped to handle the impact of COVID-19-related costs, (3) was experiencing a decline in premium revenues because of a failure to capture risk adjustment on newly added lives, and (4) all of the foregoing was reasonably likely to have a material negative impact on Bright Healths business and financial condition.

The truth emerged on Nov. 11, 2021, when Bright Health reported a whopping Q3 2021 $296.7 million net loss, or roughly $237.5 million higher than the prior years period, and blamed the results on a sharp increase in its MCR, COVID-19, and reduced premium revenues due to an inability to capture risk adjustment on newly added lives.

This news drove the price of Bright Health shares 32% lower to close at $4.94 on Nov. 11, 2021, and over 70% below the companys $18/share IPO price.

Were focused on investors losses and proving the defendants misled investors about the adaptability of Bright Healths business model in the face of the COVID-19 pandemic, said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in Bright Health, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Bright Health should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email BHG@hbsslaw.com.

About Hagens BermanHagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys. The firm represents investors, whistleblowers, workers, and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact: Reed Kathrein, 844-916-0895







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC